Breast Cancer Screening in Georgia: Choosing the Most Optimal and Cost-Effective Strategy

Article Oncology

Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies

Lindy M. Kregting et al.

Summary: This study evaluates the cost-effectiveness of breast cancer screening strategies in the Netherlands and finds that switching from biennial to triennial screening, with a lower starting age of 44, can increase benefits at lower costs.

INTERNATIONAL JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue

H. Amarens Geuzinge et al.

Summary: Using a simulation model to evaluate breast screening protocols, the study found that MRI screening every four years for women with extremely dense breasts is cost-effective, with a willingness to pay threshold of over €22,000 per QALY gained. More frequent MRI screening may result in higher additional costs.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

添加到收藏夹

Article Oncology

Cost-effectiveness Analysis of Breast Cancer Screening Using Mammography in Singapore: A Modeling Study

Sarocha Chootipongchaivat et al.

Summary: The current breast cancer screening program in Singapore is cost-effective and near the efficiency frontier, with starting screening at age 40 or 45 being recommended for optimal cost-effectiveness. Increasing screening attendance rates can further enhance benefits while maintaining cost-effectiveness.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

添加到收藏夹

Article Oncology

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios

Nadine Zielonke et al.

Summary: Breast cancer screening can both benefit and harm, with age playing a role in the balance between the two. A study using microsimulation modeling compared different age ranges of screening in four European countries to evaluate harm-to-benefit ratios. Adapting the age range of screening is a potential option to improve harm-to-benefit ratios, with the prioritization of considered harms and benefits impacting interpretation of results.

CANCERS (2021)

添加到收藏夹

Article Economics